全文获取类型
收费全文 | 707737篇 |
免费 | 50120篇 |
国内免费 | 1298篇 |
专业分类
耳鼻咽喉 | 9229篇 |
儿科学 | 23331篇 |
妇产科学 | 17669篇 |
基础医学 | 110847篇 |
口腔科学 | 19979篇 |
临床医学 | 64028篇 |
内科学 | 134733篇 |
皮肤病学 | 16259篇 |
神经病学 | 49949篇 |
特种医学 | 26003篇 |
外国民族医学 | 76篇 |
外科学 | 104862篇 |
综合类 | 14831篇 |
现状与发展 | 2篇 |
一般理论 | 160篇 |
预防医学 | 51515篇 |
眼科学 | 16445篇 |
药学 | 54081篇 |
3篇 | |
中国医学 | 2359篇 |
肿瘤学 | 42794篇 |
出版年
2019年 | 5479篇 |
2018年 | 7918篇 |
2017年 | 6155篇 |
2016年 | 6869篇 |
2015年 | 7635篇 |
2014年 | 10330篇 |
2013年 | 15491篇 |
2012年 | 20644篇 |
2011年 | 21647篇 |
2010年 | 12805篇 |
2009年 | 12007篇 |
2008年 | 20131篇 |
2007年 | 21647篇 |
2006年 | 22018篇 |
2005年 | 20551篇 |
2004年 | 20113篇 |
2003年 | 19052篇 |
2002年 | 18559篇 |
2001年 | 36442篇 |
2000年 | 36990篇 |
1999年 | 30464篇 |
1998年 | 7916篇 |
1997年 | 6697篇 |
1996年 | 6994篇 |
1995年 | 6655篇 |
1994年 | 6116篇 |
1993年 | 5607篇 |
1992年 | 23016篇 |
1991年 | 22968篇 |
1990年 | 22350篇 |
1989年 | 22122篇 |
1988年 | 20091篇 |
1987年 | 19455篇 |
1986年 | 18512篇 |
1985年 | 17358篇 |
1984年 | 12723篇 |
1983年 | 10768篇 |
1982年 | 5943篇 |
1979年 | 11548篇 |
1978年 | 8140篇 |
1977年 | 6851篇 |
1976年 | 6608篇 |
1975年 | 7289篇 |
1974年 | 8519篇 |
1973年 | 8156篇 |
1972年 | 7676篇 |
1971年 | 7144篇 |
1970年 | 6883篇 |
1969年 | 6316篇 |
1968年 | 5796篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
122.
123.
N. V. Bashmakova G. N. Chistiakova I. A. Gazieva Y. M. Trapeznikova D. O. Mazurov 《Gynecological endocrinology》2015,31(10):31-33
AbstractThis study was undertaken to compare the concentrations of pro- and anti-angiogenic growth factors, nitric oxide (NO) stable metabolites in maternal serum and embryonic left ventricular (LV) isovolumic relaxation time (IRT, ms) during the first trimester in two groups of women: with pregnancy conceived by assisted reproductive technologies (ART, n?=?39) and normally conceived (control group, n?=?68) pregnancy. The concentration of vasoconstrictor endothelin 1 was 45.5 times more in ART than in control group. On the contrary, the concentrations of NO stable metabolites in ART were 1.9 times less than in control women. The assessment of angiogenic suppressors in ART women demonstrates the decrease in s-endoglin concentration was 1.6 times and in soluble receptor to vascular endothelial growth factor concentration was 2.0 times in comparison with control group. There was a significant increase in LV IRT in ART embryos in comparison to control ones. These data suggest significant changes in pro- anti-angiogenic factors balance and increase in vascular impedance in ART-conceived embryos. 相似文献
124.
125.
126.
Pulina N. A. Kuznetsov A. S. Krasnova A. I. Novikova V. V. 《Pharmaceutical Chemistry Journal》2019,53(3):220-224
Pharmaceutical Chemistry Journal - N-Substituted 4-aryl-2-hydroxy-4-oxobut-2-enoic acid hydrazides and their complexes with Ni(II), Mn(II), Co(II), Cu(II), and Zn(II) were prepared. Their... 相似文献
127.
Joseph D. Westaby Susanna T. E. Cooper Khari A. Edwards Robert H. Anderson Mary N. Sheppard 《Clinical anatomy (New York, N.Y.)》2020,33(3):394-404
Congenital heart disease is a rare but important finding in adults who experience sudden death. Examination of the congenitally malformed heart has historically been considered esoteric and best left to those with expertise. The Cardiac Risk in the Young cardiovascular pathology laboratory based at St George's University of London has now received over 6,000 cases. Of these, 21 congenitally malformed hearts were retained for research and educational purposes. Hearts were assessed using sequential segmental analysis, and causes of death were adjudicated based on thorough macroscopic examination and histology. Congenital malformations that were encountered included atrial septal defects, ventricular septal defects, tetralogy of Fallot, and transposition of the great arteries in both its regular and congenitally corrected variants. Findings also included hearts with mirror-imaged and isomeric atrial appendages. Direct causes of death included myocardial fibrosis, pulmonary hypertension, and hemorrhage. A small but notable proportion did not reveal a substrate for arrhythmia, raising the question of whether the terminal event was due to the congenital heart disease itself, or an underlying channelopathy. Here, we demonstrate the value of simple sequential segmental analysis in describing and categorizing the cases, with the concept of the “morphological method” serving to identify the distinguishing features of the cardiac components. Clin. Anat. 33:394–404, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
128.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
129.
130.
Letter: faecal volatile organic metabolites,promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply
下载免费PDF全文
![点击此处可从《Alimentary pharmacology & therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
I. Ahmed R. Greenwood B. Costello N. Ratcliffe C. Probert 《Alimentary pharmacology & therapeutics》2016,43(11):1241-1242